TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/26/21 16:35 | 10/22/21 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund, L.P. | CA | T | S.m | -929 | 1.51 | 0 | -616 | -20 | 2,443 | D | |||||||||||||||
9/22/20 17:21 | 9/18/20 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Venbio Global Strategic Fund, L.P. | CA | TH | See Rema | P.d | 2,990 | 13.00 | 0 | 230 | 8 | 3,059 | D | ||||||||||||||
4/1/19 17:35 | 4/1/19 | DTIL | Precision Biosciences Inc | DE | Health | BioPrd | Biological Products, (No Diag | Venbio Global Strategic Fund, L.P. | CA | DT | P.d | 800 | 16.00 | 0 | 50 | 1 | 4,265 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |